In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti-PD-1/PD-L1 Therapies.
Denis M, Grasselly C, Choffour PA, Wierinckx A, Mathé D, Chettab K, Tourette A, Talhi N, Bourguignon A, Birzele F, Kress E, Jordheim LP, Klein C, Matera EL, Dumontet C.
Denis M, et al. Among authors: birzele f.
Cancer Immunol Res. 2022 Aug 3;10(8):1013-1027. doi: 10.1158/2326-6066.CIR-21-0802.
Cancer Immunol Res. 2022.
PMID: 35679518